Citations (129)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Roberta Soares Faccion, Lidia Maria Magalhães Rezende, Sérgio de Oliveira Romano, Ricardo de Sá Bigni, Gelcio Luiz Quintella Mendes & Raquel Ciuvalschi Maia. (2012) Centroblastic Diffuse Large B Cell Lymphoma Displays Distinct Expression Pattern and Prognostic Role of Apoptosis Resistance Related Proteins. Cancer Investigation 30:5, pages 404-414.
Read now
Read now
Jagat R Kanwar, Sishir K Kamalapuram & Rupinder K Kanwar. (2010) Targeting survivin in cancer: patent review. Expert Opinion on Therapeutic Patents 20:12, pages 1723-1737.
Read now
Read now
Julia V Kichina, Anna Goc, Belal Al-Husein, Payaningal R Somanath & Eugene S Kandel. (2010) PAK1 as a therapeutic target. Expert Opinion on Therapeutic Targets 14:7, pages 703-725.
Read now
Read now
Puja Sapra, Maoliang Wang, Raj Bandaru, Hong Zhao, LeeM. Greenberger & IvanD. Horak. (2010) Down-Modulation of Survivin Expression and Inhibition of Tumor Growth In Vivo by EZN-3042, A Locked Nucleic Acid Antisense Oligonucleotide. Nucleosides, Nucleotides & Nucleic Acids 29:2, pages 97-112.
Read now
Read now
Malte Buchholz & Thomas M Gress. (2009) Molecular changes in pancreatic cancer. Expert Review of Anticancer Therapy 9:10, pages 1487-1497.
Read now
Read now
Articles from other publishers (124)
Jerry Xiao, Joseph R. McGill, Apsra Nasir, Alexander Lekan, Bailey Johnson, Devan J. Wilkins, Gray W. Pearson, Kandice Tanner, Hani Goodarzi, Eric Glasgow, Richard Schlegel & Seema Agarwal. (2022) Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231. Molecular Biomedicine 3:1.
Crossref
Crossref
Noha Said Helal, Zeinab Omran & Mona Moussa. (2022) Assessment of survivin and p27 expression as potential prognostic markers in urothelial cell carcinoma of urinary bladder in Egyptian patients. African Journal of Urology 28:1.
Crossref
Crossref
Mohammed A. S. Abourehab, Sheersha Pramanik, Mohamed A. Abdelgawad, Bassam M. Abualsoud, Ammar Kadi, Mohammad Javed Ansari & A. Deepak. (2022) Recent Advances of Chitosan Formulations in Biomedical Applications. International Journal of Molecular Sciences 23:18, pages 10975.
Crossref
Crossref
Xun Weng, YangYang & Yujiao Cai. (2022) Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients. Disease Markers 2022, pages 1-8.
Crossref
Crossref
Dariimaa Ganbat, Bat-Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Ambaga Miyegombo, Gantsetseg Garmaa, Yoshihisa Takahashi, Ryuji Fukuzawa, Ichiro Mori, Takayuki Shiomi, Akinori Nakata & Yasuhiko Tomita. (2022) Use of the Naphthoquinone YM155 (Sepantronium Bromide) in the Treatment of Cancer: A Systematic Review and Meta-Synthesis. Oncologie 24:2, pages 195-225.
Crossref
Crossref
Parinaz Zivarpour, Jamal Hallajzadeh, Zatollah Asemi, Fatemeh Sadoughi & Mehran Sharifi. (2021) Chitosan as possible inhibitory agents and delivery systems in leukemia. Cancer Cell International 21:1.
Crossref
Crossref
Mohamed E. Alkafafy, Samy M. Sayed, Ahmed M. El‐Shehawi, Samir El‐Shazly, Samy Farouk, Saqer S. Alotaibi, Doaa A. Madkour, Sahar H. Orabi, Hamed T. Elbaz & Mohamed M. Ahmed. (2021)
Moringa oleifera
ethanolic extract ameliorates the testicular dysfunction resulted from HFD‐induced obesity rat model
. Andrologia 53:8.
Crossref
Crossref
Hemavathy Subramaiam, Wan-Loy Chu, Ammu Kutty Radhakrishnan, Srikumar Chakravarthi, Kanga Rani Selvaduray & Yih-Yih Kok. (2021) Evaluating Anticancer and Immunomodulatory Effects of Spirulina (Arthrospira) platensis and Gamma-Tocotrienol Supplementation in a Syngeneic Mouse Model of Breast Cancer. Nutrients 13:7, pages 2320.
Crossref
Crossref
Hassan H. Fakih, Adam Katolik, Elise Malek-Adamian, Johans J. Fakhoury, Sepideh Kaviani, Masad J. Damha & Hanadi F. Sleiman. (2021) Design and enhanced gene silencing activity of spherical 2′-fluoroarabinose nucleic acids (FANA-SNAs). Chemical Science 12:8, pages 2993-3003.
Crossref
Crossref
Yanhua Zhang, Yang Dong, Hao Fu, Hui Huang, Zhihua Wu, Meng Zhao, Xupeng Yang, Qianqian Guo, Yourong Duan & Ying Sun. (2021) Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance. Biomaterials 269, pages 120478.
Crossref
Crossref
Atieh Rafatmanesh, Mohaddeseh Behjati, Narges Mobasseri, Mostafa Sarvizadeh, Tahereh Mazoochi & Mohammad Karimian. (2019) The survivin molecule as a double‐edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer. Journal of Cellular Physiology 235:2, pages 725-744.
Crossref
Crossref
Zheng WanXiaohong ZhangYuyang LuoBin Zhao. (2019) Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Genetic Testing and Molecular Biomarkers 23:11, pages 766-777.
Crossref
Crossref
Magdalena Stobiecka, Katarzyna Ratajczak & Slawomir Jakiela. (2019) Toward early cancer detection: Focus on biosensing systems and biosensors for an anti-apoptotic protein survivin and survivin mRNA. Biosensors and Bioelectronics 137, pages 58-71.
Crossref
Crossref
Cenk Daglioglu & Fatma Necmiye Kaci. (2019) Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy. International Journal of Pharmaceutics 561, pages 74-81.
Crossref
Crossref
Ghazala Khan, Kim Orchard & Barbara-ann Guinn. (2019) Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia. Journal of Clinical Medicine 8:2, pages 134.
Crossref
Crossref
Rong Yan, Jie Chen, Jianhao Wang, Jiaming Rao, Xuancheng Du, Yongming Liu, Leshuai Zhang, Lin Qiu, Bo Liu, Yuan‐Di Zhao, Pengju Jiang, Chunying Chen & Yong‐Qiang Li. (2018) A NanoFlare‐Based Strategy for In Situ Tumor Margin Demarcation and Neoadjuvant Gene/Photothermal Therapy. Small 14:50, pages 1802745.
Crossref
Crossref
Min‑Gu Lee, Kyu‑Shik Lee & Kyung‑Soo Nam. (2018) The association of changes in RAD51 and survivin expression levels with the proton beam sensitivity of Capan‑1 and Panc‑1 human pancreatic cancer cells. International Journal of Oncology.
Crossref
Crossref
Junguo Ma & Xiaoyu Li. (2018) Insight into the negative impact of ionic liquid: A cytotoxicity mechanism of 1-methyl-3-octylimidazolium bromide. Environmental Pollution 242, pages 1337-1345.
Crossref
Crossref
Marcin Wojnilowicz, Quinn A. Besford, Yun-Long Wu, Xian Jun Loh, Julia A. Braunger, Agata Glab, Christina Cortez-Jugo, Frank Caruso & Francesca Cavalieri. (2018) Glycogen-nucleic acid constructs for gene silencing in multicellular tumor spheroids. Biomaterials 176, pages 34-49.
Crossref
Crossref
Hui Lyu, Jingcao Huang, Zhimin He & Bolin Liu. (2018) Epigenetic mechanism of survivin dysregulation in human cancer. Science China Life Sciences 61:7, pages 808-814.
Crossref
Crossref
Katarzyna Ratajczak, Bartlomiej E. Krazinski, Anna E. Kowalczyk, Beata Dworakowska, Slawomir Jakiela & Magdalena Stobiecka. (2018) Hairpin–Hairpin Molecular Beacon Interactions for Detection of Survivin mRNA in Malignant SW480 Cells. ACS Applied Materials & Interfaces 10:20, pages 17028-17039.
Crossref
Crossref
Sanam Arami, Majid Mahdavi, Mohammad-Reza Rashidi, Reza Yekta, Mohammad Rahnamay, Leila Molavi, Mohammad-Saeid Hejazi & Nasser Samadi. (2017) Apoptosis induction activity and molecular docking studies of survivin siRNA carried by Fe3O4-PEG-LAC-chitosan-PEI nanoparticles in MCF-7 human breast cancer cells. Journal of Pharmaceutical and Biomedical Analysis 142, pages 145-154.
Crossref
Crossref
Wei Huang, Liqing Chen, Lin Kang, Mingji Jin, Ping Sun, Xin Xin, Zhonggao Gao & You Han Bae. (2017) Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs. Advanced Drug Delivery Reviews 115, pages 82-97.
Crossref
Crossref
Zhichen Pu, Guang-Zhen Wu & QiFei Wang. (2017) Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis. Oncotarget 8:12, pages 19825-19833.
Crossref
Crossref
S Arami, MR Rashidi, M Mahdavi, M Fathi & AA Entezami. (2016)
Synthesis and characterization of Fe
3
O
4
-PEG-LAC-chitosan-PEI nanoparticle as a survivin siRNA delivery system
. Human & Experimental Toxicology 36:3, pages 227-237.
Crossref
Crossref
Liying Geng & Jing Wang. (2017) Molecular effectors of radiation resistance in colorectal cancer. Precision Radiation Oncology 1:1, pages 27-33.
Crossref
Crossref
Xiang YanHan Su. (2017) YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells. Medical Science Monitor 23, pages 1963-1972.
Crossref
Crossref
Cenk Daglioglu & Burcu Okutucu. (2016) Therapeutic Effects of AICAR and DOX Conjugated Multifunctional Nanoparticles in Sensitization and Elimination of Cancer Cells via Survivin Targeting. Pharmaceutical Research 34:1, pages 175-184.
Crossref
Crossref
Changqing Su. (2016) Survivin in survival of hepatocellular carcinoma. Cancer Letters 379:2, pages 184-190.
Crossref
Crossref
Junguo Ma, Yiyi Feng, Yang Liu & Xiaoyu Li. (2016) PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway. Chemosphere 157, pages 241-249.
Crossref
Crossref
Rita Q. Cruz, Catarina M. Morais, Ana M. Cardoso, Sandra G. Silva, Maria L. Vale, Eduardo F. Marques, Maria C. Pedroso de Lima & Amália S. Jurado. (2016) Enhancing glioblastoma cell sensitivity to chemotherapeutics: A strategy involving survivin gene silencing mediated by gemini surfactant-based complexes. European Journal of Pharmaceutics and Biopharmaceutics 104, pages 7-18.
Crossref
Crossref
Adam Rhodes & Thomas Hillen. (2016) Mathematical Modeling of the Role of Survivin on Dedifferentiation and Radioresistance in Cancer. Bulletin of Mathematical Biology 78:6, pages 1162-1188.
Crossref
Crossref
Meng-dong Liu, Shi-jiang Xiong, Fei Tan & Yi Liu. (2016) Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression. Acta Pharmacologica Sinica 37:5, pages 687-697.
Crossref
Crossref
Cenk Daglioglu & Burcu Okutucu. (2016) Synthesis and Characterization of AICAR and DOX Conjugated Multifunctional Nanoparticles as a Platform for Synergistic Inhibition of Cancer Cell Growth. Bioconjugate Chemistry 27:4, pages 1098-1111.
Crossref
Crossref
Seyed H. Ghaffari, Meysam Yousefi, Majid Zaki Dizaji, Majid Momeny, Davood Bashash, Ali Zekri, Kamran Alimoghaddam & Ardeshir Ghavamzadeh. (2016) Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism. Asian Pacific Journal of Cancer Prevention 17:3, pages 1553-1564.
Crossref
Crossref
Xiao Jiao Cheng, Jia Cheng Lin, Yan Fei Ding, Liming Zhu, Jing Ye & Shui Ping Tu. (2016) Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues. Oncotarget 7:6, pages 7096-7109.
Crossref
Crossref
Ryousei Sasaki, Shigeki Ito, Maki Asahi & Yoji Ishida. (2015) YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells. Leukemia Research 39:12, pages 1473-1479.
Crossref
Crossref
SIDA QIN, CHONGWEN XU, SHUO LI, XIFANG WANG, XIN SUN, PEILI WANG, BOXIANG ZHANG & HONG REN. (2015) Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer. Oncology Reports 34:5, pages 2656-2664.
Crossref
Crossref
Francesca Cavalieri, Giovanni L. Beretta, Jiwei Cui, Julia A. Braunger, Yan Yan, Joseph J. Richardson, Stella Tinelli, Marco Folini, Nadia Zaffaroni & Frank Caruso. (2015) Redox-Sensitive PEG–Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells. Biomacromolecules 16:7, pages 2168-2178.
Crossref
Crossref
YANSHENG GAO, LINGZHEN LI & LAIJUN SONG. (2015) Expression of p16 and Survivin in gliomas and their correlation with cell proliferation. Oncology Letters 10:1, pages 301-306.
Crossref
Crossref
Ji-Ae Shin, Mi Heon Ryu, Ki-Han Kwon, BuYoung Choi & Sung-Dae Cho. (2015)
Down-regulation of Akt by methanol extracts of
Impatiens balsamina
L. promotes apoptosis in human oral squamous cell carcinoma cell lines
. Journal of Oral Pathology & Medicine 44:6, pages 420-428.
Crossref
Crossref
Sang Yoon Jung, Chulwon Kim, Wan-Seok Kim, Seok-Geun Lee, Jun-Hee Lee, Bum Sang Shim, Sung-Hoon Kim, Kyoo Seok Ahn & Kwang Seok Ahn. (2015) Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM-5 Cells. Phytotherapy Research 29:7, pages 1062-1072.
Crossref
Crossref
Yunhui Hu, Kun Xu & Ernesto Yagüe. (2015) miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer. Breast Cancer Research and Treatment 151:2, pages 269-280.
Crossref
Crossref
Neha Singh, Subramanian Krishnakumar, Rupinder K. Kanwar, Chun Hei Antonio Cheung & Jagat R. Kanwar. (2015) Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers. Drug Discovery Today 20:5, pages 578-587.
Crossref
Crossref
Giuseppina Salzano, Gemma Navarro, Malav S. Trivedi, Giuseppe De Rosa & Vladimir P. Torchilin. (2015) Multifunctional Polymeric Micelles Co-loaded with Anti–Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer. Molecular Cancer Therapeutics 14:4, pages 1075-1084.
Crossref
Crossref
Amanda M. Smith, Erica B. Little, Andjelija Zivanovic, Priscilla Hong, Alfred K.S. Liu, Rachel Burow, Caedyn Stinson, Andrew R. Hallahan & Andrew S. Moore. (2015) Targeting Survivin with YM155 (Sepantronium Bromide): A novel therapeutic strategy for paediatric acute myeloid leukaemia. Leukemia Research 39:4, pages 435-444.
Crossref
Crossref
Gang Chen, Di Liu, Chunbai He, Theodore R. Gannett, Wenbin Lin & Yossi Weizmann. (2015) Enzymatic Synthesis of Periodic DNA Nanoribbons for Intracellular pH Sensing and Gene Silencing. Journal of the American Chemical Society 137:11, pages 3844-3851.
Crossref
Crossref
Hua Guo, Yuexun Wang, Tao Song, Tao Xin, Zhiming Zheng, Peng Zhong & Xiaoli Zhang. (2014) Silencing of Survivin Using YM155 Inhibits Invasion and Suppresses Proliferation in Glioma Cells. Cell Biochemistry and Biophysics 71:2, pages 587-593.
Crossref
Crossref
Min-Beom Kim, Chulwon Kim, Won-Seok Chung, Jae-Heung Cho, Dongwoo Nam, Sung-Hoon Kim & Kwang Seok Ahn. (2015) The Hydrolysed Products of Iridoid Glycosides Can Enhance Imatinib Mesylate-Induced Apoptosis in Human Myeloid Leukaemia Cells. Phytotherapy Research 29:3, pages 434-443.
Crossref
Crossref
Shang Xie, Hui Xu, Xiaofeng Shan, Baozhong Liu, Kan Wang & Zhigang Cai. (2015) Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis. PLOS ONE 10:2, pages e0116517.
Crossref
Crossref
Letteria Minutoli, Salvatore Arena, Pietro Antonuccio, Carmelo Romeo, Alessandra Bitto, Carlo Magno, Mariagrazia Rinaldi, Antonio Micali, Natasha Irrera, Gabriele Pizzino, Federica Galfo, Francesco Squadrito, Domenica Altavilla & Herbert Marini. (2015) Role of Inhibitors of Apoptosis Proteins in Testicular Function and Male Fertility: Effects of Polydeoxyribonucleotide Administration in Experimental Varicocele. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Viviana A. Rivarola & Ingrid Sol Cogno. 2015. Resistance to Photodynamic Therapy in Cancer. Resistance to Photodynamic Therapy in Cancer
163
182
.
Qin Qin, Hongyan Cheng, Jing Lu, Liangliang Zhan, Jianchao Zheng, Jing Cai, Xi Yang, Liping Xu, Hongcheng Zhu, Chi Zhang, Jia Liu, Jianxin Ma, Xizhi Zhang, Shengbin Dai & Xinchen Sun. (2014) Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
Salma Khan, Heather Ferguson Bennit, David Turay, Mia Perez, Saied Mirshahidi, Yuan Yuan & Nathan R Wall. (2014) Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 14:1.
Crossref
Crossref
Letteria Minutoli, Domenica Altavilla, Herbert Marini, Mariagrazia Rinaldi, Natasha Irrera, Gabriele Pizzino, Alessandra Bitto, Salvatore Arena, Sebastiano Cimino, Francesco Squadrito, Giorgio Ivan Russo & Giuseppe Morgia. (2014) Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene. Journal of Biomedical Science 21:1.
Crossref
Crossref
Christiana M. Neophytou, Constantina Constantinou, Panagiotis Papageorgis & Andreas I. Constantinou. (2014) d-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. Biochemical Pharmacology 89:1, pages 31-42.
Crossref
Crossref
Anastasia Pavlidou, Christos Kroupis, Nikolaos Goutas, Maria Dalamaga & Kleanthi Dimas. (2014) Validation of a Real-Time Quantitative Polymerase Chain Reaction Method for the Quantification of 3 Survivin Transcripts and Evaluation in Breast Cancer Tissues. Clinical Breast Cancer 14:2, pages 122-131.
Crossref
Crossref
JUNYAN ZHANG, ZHI ZHU, ZHE SUN, XUREN SUN, ZHENNING WANG & HUIMIAN XU. (2014) Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels. Molecular Medicine Reports 9:2, pages 600-606.
Crossref
Crossref
Shunzeng Lv, Ekaterina Turlova, Shigang Zhao, Huihui Kang, Mingzhi Han & Hong-Shuo Sun. (2013) Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis. Tumor Biology 35:2, pages 1565-1574.
Crossref
Crossref
Petr Krůpa, Svatopluk Řehák, Daniel Diaz-Garcia & Stanislav Filip. (2014) NANOTECHNOLOGY – NEW TRENDS IN THE TREATMENT OF BRAIN TUMOURS. Acta Medica (Hradec Kralove, Czech Republic) 57:4, pages 142-150.
Crossref
Crossref
Yudan Chi, Xiang Wang, Yong Yang, Chao Zhang, Hildegund C J Ertl & Dongming Zhou. (2014) Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models. Molecular Therapy - Nucleic Acids 3, pages e208.
Crossref
Crossref
Chanhoo Jeon, Myong Kim, Cheol Kwak, Hyeon Hoe Kim & Ja Hyeon Ku. (2013) Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis. PLoS ONE 8:10, pages e76719.
Crossref
Crossref
Anna Carbone, Marzia Pennati, Barbara Parrino, Alessia Lopergolo, Paola Barraja, Alessandra Montalbano, Virginia Spanò, Stefania Sbarra, Valentina Doldi, Michelandrea De Cesare, Girolamo Cirrincione, Patrizia Diana & Nadia Zaffaroni. (2013)
Novel 1
H
-Pyrrolo[2,3-
b
]pyridine Derivative Nortopsentin Analogues: Synthesis and Antitumor Activity in Peritoneal Mesothelioma Experimental Models
. Journal of Medicinal Chemistry 56:17, pages 7060-7072.
Crossref
Crossref
DONG XU, QINGGUANG WANG, YONG AN & LIJIAN XU. (2013) miR-203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Molecular Medicine Reports 8:2, pages 379-384.
Crossref
Crossref
Fan Li, Xuedong Yin, Xinrong Luo, Hong-Yuan Li, Xinliang Su, Xiao-Yi Wang, Li Chen, Ke Zheng & Guo-Sheng Ren. (2013) Livin promotes progression of breast cancer through induction of epithelial–mesenchymal transition and activation of AKT signaling. Cellular Signalling 25:6, pages 1413-1422.
Crossref
Crossref
Xia-Bin LiShi-Ning LiZhi-Hui YangLing CaoFang-Lei DuanXing-Wang Sun. (2013)
Polymorphisms of
Survivin
and Its Protein Expression Are Associated with Colorectal Cancer Susceptibility in Chinese Population
. DNA and Cell Biology 32:5, pages 236-242.
Crossref
Crossref
Kothandharaman Subramaniam, Jayshree L. Hirpara, Lisa Tucker-Kellogg, Greg Tucker-Kellogg & Shazib Pervaiz. (2013) FLIP: A flop for execution signals. Cancer Letters 332:2, pages 151-155.
Crossref
Crossref
Dario C. Altieri. (2013) Targeting survivin in cancer. Cancer Letters 332:2, pages 225-228.
Crossref
Crossref
Roser Mir, Avelina Tortosa, Fina Martinez‐Soler, August Vidal, Enric Condom, Alba Pérez‐Perarnau, Tatiana Ruiz‐Larroya, Joan Gil & Pepita Giménez‐Bonafé. (2012)
Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in
TP53
wild‐type ovarian cancer cells
. International Journal of Cancer 132:7, pages 1525-1536.
Crossref
Crossref
Jing ChenCynthia A. Pise-Masison, Joanna H. Shih, John C. MorrisJohn E. JanikKevin C. ConlonAnne Keating & Thomas A. Waldmann. (2013) Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia. Blood 121:11, pages 2029-2037.
Crossref
Crossref
Xiaopeng Cai, Shuai Ma, Ming Gu, Cong Zu, Wenzhi Qu & Xinyu Zheng. (2012) Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagnostic Pathology 7:1.
Crossref
Crossref
B. Greve, F. Sheikh-Mounessi, B. Kemper, I. Ernst, M. Götte & H.T. Eich. (2012) Survivin, a target to modulate the radiosensitivity of Ewing’s sarcomaSurvivin, ein Zielmolekül zur Modulation der Strahlenempfindlichkeit von Ewing-Sarkomen. Strahlentherapie und Onkologie 188:11, pages 1038-1047.
Crossref
Crossref
Qinglian Hu, Wen Li, Xiurong Hu, Qida Hu, Jie Shen, Xue Jin, Jun Zhou, Guping Tang & Paul K. Chu. (2012) Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. Biomaterials 33:27, pages 6580-6591.
Crossref
Crossref
Md. Motarab Hossain, Naren L. Banik & Swapan K. Ray. (2012) Survivin knockdown increased anti-cancer effects of (−)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Experimental Cell Research 318:13, pages 1597-1610.
Crossref
Crossref
Hamdy A.A. Aly. (2012) Cancer therapy and vaccination. Journal of Immunological Methods 382:1-2, pages 1-23.
Crossref
Crossref
Sara Ekeblad, Margareta Halin Lejonklou, Peter Stålberg & Britt Skogseid. (2011) Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors. World Journal of Surgery 36:6, pages 1411-1418.
Crossref
Crossref
Xiao‐Yuan Chu, Long‐Bang Chen, Jing‐Hua Wang, Quan‐Sheng Su, Ji‐Rong Yang, Yong Lin, Li‐Jun Xue, Xiao‐Bei Liu & Xiao‐Bei Mo. (2011) Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. Journal of Surgical Oncology 105:6, pages 520-528.
Crossref
Crossref
Kshitij Srivastava, Anvesha Srivastava & Balraj Mittal. (2011) Survivin promoter −31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis. Molecular Biology Reports 39:2, pages 1509-1516.
Crossref
Crossref
HAO DENG, HONGYAN ZHEN, ZHENGQI FU, XUAN HUANG, HONGYAN ZHOU & LIJIANG LIU. (2012) The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer. Oncology Letters 3:1, pages 193-199.
Crossref
Crossref
Jiamu Du, Alexander E. Kelly, Hironori Funabiki & Dinshaw J. Patel. (2012) Structural Basis for Recognition of H3T3ph and Smac/DIABLO N-terminal Peptides by Human Survivin. Structure 20:1, pages 185-195.
Crossref
Crossref
Yaghub Pazhang, Shahin Ahmadian, Massoud Mahmoudian & Mahshid Shafiezadeh. (2010) Berberine-induced apoptosis via decreasing the survivin protein in K562 cell line. Medical Oncology 28:4, pages 1577-1583.
Crossref
Crossref
S. Hendruschk, R. Wiedemuth, A. Aigner, K. Topfer, M. Cartellieri, D. Martin, M. Kirsch, C. Ikonomidou, G. Schackert & A. Temme. (2011) RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Neuro-Oncology 13:10, pages 1074-1089.
Crossref
Crossref
Gou Young Kim, Sung-Jig Lim & Youn Wha Kim. (2011) Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas. Modern Pathology 24:10, pages 1336-1347.
Crossref
Crossref
Sebastian Reichert, Claus Rödel, Johanna Mirsch, Patrick N. Harter, Maja T. Tomicic, Michel Mittelbronn, Bernd Kaina & Franz Rödel. (2011) Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma. Radiotherapy and Oncology 101:1, pages 51-58.
Crossref
Crossref
Jonathan M. Hernandez, Jeffrey M. Farma, Domenico Coppola, Ardeshir Hakam, William J. Fulp, Dung-Tsa Chen, Erin M. Siegel, Timothy J. Yeatman & David Shibata. (2011) Expression of the Antiapoptotic Protein Survivin in Colon Cancer. Clinical Colorectal Cancer 10:3, pages 188-193.
Crossref
Crossref
Ji Young Heo, Hyun Jung Kim, Sung-Moo Kim, Kyung-Ran Park, Sang-Yoon Park, Seong Won Kim, Dongwoo Nam, Hyeung-Jin Jang, Seok-Geun Lee, Kyoo Seok Ahn, Sung-Hoon Kim, Bum Sang Shim, Seung-Hoon Choi & Kwang Seok Ahn. (2011) Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Letters 308:1, pages 71-80.
Crossref
Crossref
S. Trabulo, A. M. Cardoso, T. Santos-Ferreira, A. L. Cardoso, S. Simões & M. C. Pedroso de Lima. (2011) Survivin Silencing as a Promising Strategy To Enhance the Sensitivity of Cancer Cells to Chemotherapeutic Agents. Molecular Pharmaceutics 8:4, pages 1120-1131.
Crossref
Crossref
Aamir Ahmad, Wael A. Sakr & KM Wahidur Rahman. (2011) Mechanisms and Therapeutic Implications of Cell Death Induction by Indole Compounds. Cancers 3:3, pages 2955-2974.
Crossref
Crossref
Yang Gao, Min Zhang, Huafei Zhang, Xianghui Yu, Wei Kong, Xiao Zha & Yuqing Wu. (2011) Thermal Stability and Structural Variations of Survivin and Its Deletants in Aqueous Solution as Revealed by Spectroscopy. The Journal of Physical Chemistry B 115:21, pages 7038-7044.
Crossref
Crossref
Pablo E. Vivas-Mejia, Cristian Rodriguez-Aguayo, Hee-Dong Han, Mian M.K. Shahzad, Fatma Valiyeva, Mineko Shibayama, Arturo Chavez-Reyes, Anil K. Sood & Gabriel Lopez-Berestein. (2011) Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer. Clinical Cancer Research 17:11, pages 3716-3726.
Crossref
Crossref
Shaguna Seth, Yoshiyuki Matsui, Kathy Fosnaugh, Yan Liu, Narendra Vaish, Roger Adami, Pierrot Harvie, Rachel Johns, Gregory Severson, Tod Brown, Akihide Takagi, Susan Bell, Yan Chen, Feng Chen, Tianying Zhu, Renata Fam, Iwona Maciagiewicz, Erin Kwang, Michael McCutcheon, Ken Farber, Patrick Charmley, Michael E HoustonJr.Jr., Alan So, Michael V Templin & Barry Polisky. (2011) RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer. Molecular Therapy 19:5, pages 928-935.
Crossref
Crossref
Thilo Sprenger, Franz Rödel, Tim Beissbarth, Lena-Christin Conradi, Hilka Rothe, Kia Homayounfar, Hendrik A. Wolff, B. Michael Ghadimi, Müjdat Yildirim, Heinz Becker, Claus Rödel & Torsten Liersch. (2011) Failure of Downregulation of Survivin Following Neoadjuvant Radiochemotherapy in Rectal Cancer Is Associated with Distant Metastases and Shortened Survival. Clinical Cancer Research 17:6, pages 1623-1631.
Crossref
Crossref
Alisa L. Becker, Nicola Ivan Orlotti, Marco Folini, Francesca Cavalieri, Alexander N. Zelikin, Angus P. R. Johnston, Nadia Zaffaroni & Frank Caruso. (2011) Redox-Active Polymer Microcapsules for the Delivery of a Survivin-Specific siRNA in Prostate Cancer Cells. ACS Nano 5:2, pages 1335-1344.
Crossref
Crossref
Rosa A. Carrasco, Nancy B. Stamm, Eric Marcusson, George Sandusky, Philip Iversen & Bharvin K.R. Patel. (2011) Antisense Inhibition of Survivin Expression as a Cancer Therapeutic. Molecular Cancer Therapeutics 10:2, pages 221-232.
Crossref
Crossref
Pheruza Tarapore, Yi Shu, Peixuan Guo & Shuk-Mei Ho. (2011) Application of Phi29 Motor pRNA for Targeted Therapeutic Delivery of siRNA Silencing Metallothionein-IIA and Survivin in Ovarian Cancers. Molecular Therapy 19:2, pages 386-394.
Crossref
Crossref
Hyun Jung Kim, Sung-Moo Kim, Kyung-Ran Park, Hyeung-Jin Jang, Young-Soon Na, Kyoo Seok Ahn, Sung-Hoon Kim & Kwang Seok Ahn. (2011) Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway. Cancer Letters 301:1, pages 29-37.
Crossref
Crossref
Yang Gao, Huafei Zhang, Min Zhang, Haihong Zhang, Xianghui Yu, Wei Kong, Xiao Zha & Yuqing Wu. (2010) N-Terminal Deletion Effects of Human Survivin on Dimerization and Binding to Smac/DIABLO in Vitro. The Journal of Physical Chemistry B 114:47, pages 15656-15662.
Crossref
Crossref
Xiang Ling, Diane Calinski, Asher A Chanan-Khan, Muxiang Zhou & Fengzhi Li. (2010) Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref
Maria Simona Aguzzi, Paola Fortugno, Claudia Giampietri, Gianluca Ragone, Maurizio C. Capogrossi & Antonio Facchiano. (2010) Intracellular targets of RGDS peptide in melanoma cells. Molecular Cancer 9:1.
Crossref
Crossref
Quein Ahn, Soo-Jin Jeong, Hyo-Jung Lee, Hee-Young Kwon, Ihn Han, Hyun Seok Kim, Hyo-Jeong Lee, Eun-Ok Lee, Kwang Seok Ahn, Min-Hyung Jung, Shudong Zhu, Chang-Yan Chen & Sung-Hoon Kim. (2010) Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells. Cancer Letters 298:2, pages 212-221.
Crossref
Crossref
J. George, N. L. Banik & S. K. Ray. (2010) Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro-Oncology 12:11, pages 1088-1101.
Crossref
Crossref
Asher A. Chanan-Khan, Ivan Borrello, Kelvin P. Lee & Donna E. Reece. (2010) Development of target-specific treatments in multiple myeloma. British Journal of Haematology 151:1, pages 3-15.
Crossref
Crossref
Angela Gradilone, Arianna Petracca, Chiara Nicolazzo, Walter Gianni, Enrico Cortesi, Giuseppe Naso, Bruno Vincenzi, Cristiano Cristini, Ettore De Berardinis, Franco Di Silverio, Anna Maria Aglianò & Paola Gazzaniga. (2010) Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU International 106:5, pages 710-715.
Crossref
Crossref
C. Xiaoyuan, C. Longbang, W. Jinghua, G. Xiaoxiang, G. Huaicheng, Z. Qun & S. Haizhu. (2009) Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer. Irish Journal of Medical Science 179:3, pages 327-335.
Crossref
Crossref
. 2010. Apoptosis. Apoptosis
593
610
.
Tatsushi Yoshida, Yaqin Zhang, Leslie A. Rivera Rosado, Junjie Chen, Tahira Khan, Sun Young Moon & Baolin Zhang. (2010) Blockade of Rac1 Activity Induces G1 Cell Cycle Arrest or Apoptosis in Breast Cancer Cells through Downregulation of Cyclin D1, Survivin, and X-Linked Inhibitor of Apoptosis Protein. Molecular Cancer Therapeutics 9:6, pages 1657-1668.
Crossref
Crossref
Feng Jin, Lei Zhao, Yuan-Jin Guo, Wan-Ju Zhao, Hao Zhang, Hai-Tao Wang, Tong Shao, Shu-Ling Zhang, Yu-Jia Wei, Jun Feng, Xiao-Bing Jiang & Hong-Yang Zhao. (2010) Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells. Brain Research 1336, pages 103-111.
Crossref
Crossref
Yu-Sheng Chen, Hong-Ru Li, Ming Lin, Gang Chen, Bao-Song Xie, Neng-Luan Xu & Li-Fang Lin. (2009) Livin abrogates apoptosis of SPC-A1 cell by regulating JNKI signaling pathway. Molecular Biology Reports 37:5, pages 2241-2247.
Crossref
Crossref
Gianni Capalbo, Klaus Dittmann, Christian Weiss, Sebastian Reichert, Eva Hausmann, Claus Rödel & Franz Rödel. (2010) Radiation-Induced Survivin Nuclear Accumulation is Linked to DNA Damage Repair. International Journal of Radiation Oncology*Biology*Physics 77:1, pages 226-234.
Crossref
Crossref
In-Hee Park & Chenglong Li. (2010) Dynamic Ligand-Induced-Fit Simulation via Enhanced Conformational Samplings and Ensemble Dockings: A Survivin Example. The Journal of Physical Chemistry B 114:15, pages 5144-5153.
Crossref
Crossref
Ai-Niu Ma, Wei-Lin Huang, Zhong-Nan Wu, Ji-Fan Hu, Tao Li, Xiang-Jun Zhou & Yong-Xiang Wang. (2010) Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth. Biochemical and Biophysical Research Communications 393:4, pages 592-597.
Crossref
Crossref
Deyong Yang, Xishuang Song, Jianing Zhang, Lin Ye, Shujing Wang, Xiangyu Che, Jianbo Wang, Zhiwei Zhang, Lina Wang & Wei Shi. (2010) Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (<italic>Livin</italic>, <italic>XIAP</italic>, and <italic>Survivin</italic>) on human bladder cancer T24 cells. Acta Biochimica et Biophysica Sinica 42:2, pages 137-144.
Crossref
Crossref
C-T Yang, J-M Li, H-H Weng, Y-C Li, H-C Chen & M-F Chen. (2009) Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Cancer Gene Therapy 17:2, pages 120-130.
Crossref
Crossref
Yu-Wei Sun, Wei-Jan Huang, Che-Jen Hsiao, Yi-Cheng Chen, Pin-Hsuan Lu & Jih-Hwa Guh. (2010) Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways. The Prostate, pages n/a-n/a.
Crossref
Crossref
Chudi NdubakuFrederick CohenEugene VarfolomeevDomagoj Vucic. (2009) Targeting inhibitor of apoptosis proteins for therapeutic intervention. Future Medicinal Chemistry 1:8, pages 1509-1525.
Crossref
Crossref
Bríd M. Ryan, Norma O’Donovan & Michael J. Duffy. (2009) Survivin: A new target for anti-cancer therapy. Cancer Treatment Reviews 35:7, pages 553-562.
Crossref
Crossref
E. D. Sverdlov. (2009) Not gene therapy, but genetic surgery—the right strategy to attack cancer. Molecular Genetics, Microbiology and Virology 24:3, pages 93-113.
Crossref
Crossref
Taroh Satoh, Isamu Okamoto, Masaki Miyazaki, Ryotaroh Morinaga, Asuka Tsuya, Yoshikazu Hasegawa, Masaaki Terashima, Shinya Ueda, Masahiro Fukuoka, Yutaka Ariyoshi, Toshikazu Saito, Noriyuki Masuda, Hirokazu Watanabe, Tetsuo Taguchi, Toru Kakihara, Yumiko Aoyama, Yohko Hashimoto & Kazuhiko Nakagawa. (2009) Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors. Clinical Cancer Research 15:11, pages 3872-3880.
Crossref
Crossref
Liang Qiao & Benjamin C.Y. Wong. (2009) Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resistance Updates 12:3, pages 55-64.
Crossref
Crossref
Shang-mian Yie, Be Lou, Shang-rong Ye, Xu He, Mei Cao, Ke Xie, Nai-yao Ye, Rao Lin, Sheng-min Wu, Hai-bo Xiao & En Gao. (2009) Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 63:2, pages 284-290.
Crossref
Crossref
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson & David P. Berry. (2009) Prognostic molecular markers in cholangiocarcinoma: A systematic review. European Journal of Cancer 45:1, pages 33-47.
Crossref
Crossref
Mong-Hong Lee, Huiling Yang, Ruiying Zhao & Sai-Ching J. Yeung. 2009. Apoptosis in Carcinogenesis and Chemotherapy. Apoptosis in Carcinogenesis and Chemotherapy
273
294
.
Wentao Hui, Ying Zan, Xijng Wang, Huafeng Kang, Haitao Guan & Xiaobin Ma. (2008) Expression of Survivin, p53 and its relationship with apoptosis, proliferation in hepatocellular carcinoma (HCC). Journal of Nanjing Medical University 22:4, pages 255-259.
Crossref
Crossref
Zhenghua Wang, Minwen Ha & Zhitu Zhu. (2008) The relationship between the expression of Survivin in human non-small cell lung cancer and microvessel density. The Chinese-German Journal of Clinical Oncology 7:7, pages 387-389.
Crossref
Crossref